U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Plantar hyperkeratosis

MedGen UID:
341658
Concept ID:
C1856954
Finding
Synonym: Plantar hyperkeratoses
 
HPO: HP:0007556

Definition

Hyperkeratosis affecting the sole of the foot. [from HPO]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVPlantar hyperkeratosis

Conditions with this feature

Junctional epidermolysis bullosa, non-Herlitz type
MedGen UID:
82798
Concept ID:
C0268374
Disease or Syndrome
Junctional epidermolysis bullosa (JEB) is characterized by fragility of the skin and mucous membranes, manifest by blistering with little or no trauma. Blistering may be severe and granulation tissue can form on the skin around the oral and nasal cavities, fingers and toes, and internally around the upper airway. Blisters generally heal with no significant scarring. Broad classification of JEB includes JEB generalized severe and JEB generalized intermediate. In JEB generalized severe, blisters are present at birth or become apparent in the neonatal period. Congenital malformations of the urinary tract and bladder may also occur. In JEB generalized intermediate, the phenotype may be mild with blistering localized to hands, feet, knees, and elbows with or without renal or ureteral involvement. Some individuals never blister after the newborn period. Additional features shared by JEB and the other major forms of epidermolysis bullosa (EB) include congenital localized absence of skin (aplasia cutis congenita), milia, nail dystrophy, scarring alopecia, hypotrichosis, pseudosyndactyly, and other contractures.
Odonto-onycho-dermal dysplasia
MedGen UID:
208666
Concept ID:
C0796093
Disease or Syndrome
Odontoonychodermal dysplasia (OODD) is an autosomal recessive disorder characterized by dry hair, severe hypodontia, smooth tongue with marked reduction of fungiform and filiform papillae, onychodysplasia, hyperkeratosis of the palms and soles, hypo- and hyperhidrosis of the skin, and atrophic patches on the face (summary by Adaimy et al., 2007; Yu et al., 2019).
Poikiloderma with neutropenia
MedGen UID:
388129
Concept ID:
C1858723
Disease or Syndrome
Poikiloderma with neutropenia (PN) is characterized by an inflammatory eczematous rash (ages 6-12 months) followed by post-inflammatory poikiloderma (age >2 years) and chronic noncyclic neutropenia typically associated with recurrent sinopulmonary infections in the first two years of life and (often) bronchiectasis. There is increased risk for myelodysplastic syndrome and, rarely, acute myelogenous leukemia. Other ectodermal findings include nail dystrophy and palmar/plantar hyperkeratosis. Most affected individuals also have reactive airway disease and some have short stature, hypogonadotropic hypogonadism, midfacial retrusion, calcinosis cutis, and non-healing skin ulcers.
Pachyonychia congenita 3
MedGen UID:
811523
Concept ID:
C3714948
Disease or Syndrome
Pachyonychia congenita (PC) is characterized by hypertrophic nail dystrophy, painful palmoplantar keratoderma and blistering, oral leukokeratosis, pilosebaceous cysts (including steatocystoma and vellus hair cysts), palmoplantar hyperhydrosis, and follicular keratoses on the trunk and extremities.
Palmoplantar keratoderma, nonepidermolytic, focal or diffuse
MedGen UID:
816724
Concept ID:
C3810394
Disease or Syndrome
Pachyonychia congenita (PC) is characterized by hypertrophic nail dystrophy, painful palmoplantar keratoderma and blistering, oral leukokeratosis, pilosebaceous cysts (including steatocystoma and vellus hair cysts), palmoplantar hyperhydrosis, and follicular keratoses on the trunk and extremities.
Epidermolysis bullosa simplex with nail dystrophy
MedGen UID:
906476
Concept ID:
C4225309
Disease or Syndrome
Autosomal recessive generalized intermediate epidermolysis bullosa simplex 5D (EBS5D) is characterized by generalized skin blistering that heals with scarring and hyperpigmentation. Nail dystrophy is severe. Mucous membranes, heart, and muscle are spared (Gostynska et al., 2015). For a discussion of genetic heterogeneity of the subtypes of EBS, see EBS1A (131760).
Autosomal dominant palmoplantar keratoderma and congenital alopecia
MedGen UID:
930338
Concept ID:
C4304669
Disease or Syndrome
Palmoplantar keratoderma and congenital alopecia-1 (PPKCA1) is a rare autosomal dominant disorder characterized by severe hyperkeratosis and congenital alopecia. Nail changes occur in some patients (summary by Castori et al., 2010). Also see PPKCA2 (212360), an autosomal recessive disorder characterized by congenital alopecia and progressive hyperkeratosis resulting in sclerodactyly, severe contractures and tapering of the digits, and pseudoainhum formation.
Epidermolytic palmoplantar keratoderma, 1
MedGen UID:
1053126
Concept ID:
CN377798
Disease or Syndrome
Epidermolytic palmoplantar keratoderma-1 (EPPK1) is an autosomal dominant skin disorder characterized clinically by diffuse, yellow thickening of the skin of the palms and soles. There is no extension of the keratoderma to dorsal surfaces of hands and feet, inner wrists, and Achilles tendon area (transgrediens). Knuckle pads may be present in some individuals (summary by Kuster et al., 2002, Chiu et al., 2007). Genetic Heterogeneity of Epidermolytic Palmoplantar Keratoderma Epidermolytic palmoplantar keratoderma-2 (EPPK2; 620411) is caused by mutation in the keratin-1 gene (KRT1; 139350) on chromosome 12q13. Classification of Palmoplantar Keratoderma PPK has been classified into diffuse, focal, and punctate forms according to the pattern of hyperkeratosis on the palms and soles (Lucker et al., 1994). Diffuse PPK develops at birth or shortly thereafter and involves the entire palm and sole with a sharp cutoff at an erythematous border; there are no lesions outside the volar skin, and, in particular, no follicular or oral lesions. In contrast, focal PPK is a late-onset form in which focal hyperkeratotic lesions develop in response to mechanical trauma; an important distinguishing feature is the presence of lesions at other body sites, e.g., oral and follicular hyperkeratosis (Stevens et al., 1996). Palmoplantar keratodermas can be further subdivided histologically into epidermolytic and nonepidermolytic PPK (Risk et al., 1994). Genetic Heterogeneity of Palmoplantar Keratoderma Nonepidermolytic palmoplantar keratoderma (NEPPK; 600962) is caused by mutation in the KRT1 gene. A focal form of NEPPK (FNEPPK1; 613000) is caused by mutation in the KRT16 gene (148067). Another focal form, FNEPPK2 (616400), is caused by mutation in the TRPV3 gene (607066); mutation in TRPV3 can also cause Olmsted syndrome (OLMS; 614594), a severe mutilating form of PPK. The diffuse Bothnian form of NEPPK (PPKB; 600231) is caused by mutation in the AQP5 gene (600442). The Nagashima type of nonepidermolytic diffuse PPK (PPKN; 615598) is caused by mutation in the SERPINB7 gene (603357). A generalized form of epidermolytic hyperkeratosis (EHK; 113800), also designated bullous congenital ichthyosiform erythroderma (BCIE), is caused by mutation in the keratin genes KRT1 and KRT10 (148080). For a discussion of punctate PPK, see 148600; for a discussion of striate PPK, see 148700.

Professional guidelines

PubMed

Chu HT, Dinh Duong TA, Le DH, Le TV, Nguyen BB, Dang CV, Vu QV
Pediatr Neonatol 2023 Jul;64(4):405-410. Epub 2023 Jan 3 doi: 10.1016/j.pedneo.2022.09.018. PMID: 36658016
Porter RM, Bravo AA, Smith FJD
J Am Podiatr Med Assoc 2017 Sep;107(5):428-435. doi: 10.7547/16-043. PMID: 29077501
Shwayder T
Am J Clin Dermatol 2004;5(1):17-29. doi: 10.2165/00128071-200405010-00004. PMID: 14979740

Recent clinical studies

Etiology

Kus MM, Mulayim MK, Kus C, Doganer A, Ozturk P, Temiz F, Nazik H
J Cosmet Dermatol 2023 Oct;22(10):2791-2798. Epub 2023 May 2 doi: 10.1111/jocd.15773. PMID: 37128833
Hirt PA, Castillo DE, Yosipovitch G, Keri JE
J Am Acad Dermatol 2019 Nov;81(5):1037-1057. doi: 10.1016/j.jaad.2018.12.070. PMID: 31610857
Shipman AR, Millington GW
Br J Dermatol 2011 Oct;165(4):743-50. doi: 10.1111/j.1365-2133.2011.10393.x. PMID: 21564065
Hahler B
Ostomy Wound Manage 2006 Jun;52(6):34-6, 38, 40 passim. PMID: 16799182
Scheinfeld NS
Clin Dermatol 2004 Jul-Aug;22(4):303-9. doi: 10.1016/j.clindermatol.2004.01.001. PMID: 15475230

Diagnosis

Juratli HA, Jägle S, Happle R, Avci P, Didona D, Fischer J
Acta Derm Venereol 2020 Feb 27;100(4):adv00064. doi: 10.2340/00015555-3419. PMID: 32052849Free PMC Article
Hirt PA, Castillo DE, Yosipovitch G, Keri JE
J Am Acad Dermatol 2019 Nov;81(5):1037-1057. doi: 10.1016/j.jaad.2018.12.070. PMID: 31610857
Baselga Torres E, Torres-Pradilla M
Actas Dermosifiliogr 2014 Jul-Aug;105(6):546-57. Epub 2014 Mar 31 doi: 10.1016/j.ad.2013.11.014. PMID: 24698434
Scheinfeld NS
Clin Dermatol 2004 Jul-Aug;22(4):303-9. doi: 10.1016/j.clindermatol.2004.01.001. PMID: 15475230
Montgomery RM
Cutis 1977 Dec;20(6):711-3. PMID: 590036

Therapy

Bashline BR, Bedocs PM
Cutis 2018 Sep;102(3):E19-E21. PMID: 30372722
Boada A, Carrera C, Segura S, Collgros H, Pasquali P, Bodet D, Puig S, Malvehy J
Clin Transl Oncol 2018 Nov;20(11):1373-1384. Epub 2018 May 24 doi: 10.1007/s12094-018-1891-7. PMID: 29799097
Rinderknecht JD, Goldinger SM, Rozati S, Kamarashev J, Kerl K, French LE, Dummer R, Belloni B
PLoS One 2013;8(3):e58721. Epub 2013 Mar 14 doi: 10.1371/journal.pone.0058721. PMID: 23516541Free PMC Article
Shipman AR, Millington GW
Br J Dermatol 2011 Oct;165(4):743-50. doi: 10.1111/j.1365-2133.2011.10393.x. PMID: 21564065
Dhadke SV, Kulkarni PM, Dhadke VN, Deshpande NS, Wattamwar PR
J Assoc Physicians India 2006 Mar;54:246-7. PMID: 16800355

Prognosis

Sánchez-Rodríguez R, Martínez-Quintana R, Martínez-Nova A, Martínez-Rico M, Pedrera-Zamorano JD, Chicharro-Luna E
J Tissue Viability 2023 Aug;32(3):401-405. Epub 2023 May 29 doi: 10.1016/j.jtv.2023.05.007. PMID: 37268490
Bolcato V, Barruscotti S, DE Silvestri A, Tomasini CF, Brazzelli V
Ital J Dermatol Venerol 2021 Feb;156(1):73-83. Epub 2020 Oct 21 doi: 10.23736/S2784-8671.19.06403-4. PMID: 33084262
Wang CY, Chang CK, Chou CY, Wu CJ, Chu TS, Chiao HY, Chen CY, Chen TM, Tzeng YS
Ann Plast Surg 2018 Feb;80(2S Suppl 1):S55-S58. doi: 10.1097/SAP.0000000000001304. PMID: 29369100
Scheinfeld NS
Clin Dermatol 2004 Jul-Aug;22(4):303-9. doi: 10.1016/j.clindermatol.2004.01.001. PMID: 15475230
Lee HR, Moon YS, Yeom CH, Kim KW, Chun JY, Kim HK, Choi HS, Kim DK, Chung TS
J Korean Med Sci 1997 Dec;12(6):570-5. doi: 10.3346/jkms.1997.12.6.570. PMID: 9443100Free PMC Article

Clinical prediction guides

Sánchez-Rodríguez R, Martínez-Quintana R, Martínez-Nova A, Martínez-Rico M, Pedrera-Zamorano JD, Chicharro-Luna E
J Tissue Viability 2023 Aug;32(3):401-405. Epub 2023 May 29 doi: 10.1016/j.jtv.2023.05.007. PMID: 37268490
Quaio CR, de Almeida TF, Brasil AS, Pereira AC, Jorge AA, Malaquias AC, Kim CA, Bertola DR
Clinics (Sao Paulo) 2013;68(8):1079-83. doi: 10.6061/clinics/2013(08)03. PMID: 24037001Free PMC Article
Rinderknecht JD, Goldinger SM, Rozati S, Kamarashev J, Kerl K, French LE, Dummer R, Belloni B
PLoS One 2013;8(3):e58721. Epub 2013 Mar 14 doi: 10.1371/journal.pone.0058721. PMID: 23516541Free PMC Article
Su WP, Chun SI, Hammond DE, Gordon H
Pediatr Dermatol 1990 Mar;7(1):33-8. doi: 10.1111/j.1525-1470.1990.tb01070.x. PMID: 2140447
Thomas SE, Dykes PJ, Marks R
J Invest Dermatol 1985 Nov;85(5):394-7. doi: 10.1111/1523-1747.ep12277052. PMID: 2932504

Recent systematic reviews

Reilly IN, Longhurst B, Vlahovic TC
J Am Podiatr Med Assoc 2023 Nov-Dec;113(6) doi: 10.7547/22-044. PMID: 38175699

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...